vs
Cerence Inc.（CRNC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Cerence Inc.的1.7倍（$197.9M vs $115.1M），REPLIGEN CORP净利率更高（6.7% vs -4.6%，领先11.3%），Cerence Inc.同比增速更快（126.1% vs 13.6%），Cerence Inc.自由现金流更多（$35.6M vs $17.6M），过去两年Cerence Inc.的营收复合增速更高（30.3% vs 14.4%）
Cerence Inc.是一家美国跨国软件企业，核心业务为研发面向汽车领域的人工智能语音助手技术，凭借在车载智能交互领域的技术积累，为全球多家车企提供智能化车载体验解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CRNC vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$115.1M
营收增速更快
CRNC
高出112.5%
13.6%
净利率更高
RGEN
高出11.3%
-4.6%
自由现金流更多
CRNC
多$18.1M
$17.6M
两年增速更快
CRNC
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $115.1M | $197.9M |
| 净利润 | $-5.2M | $13.3M |
| 毛利率 | 86.3% | 52.5% |
| 营业利润率 | 25.5% | 9.0% |
| 净利率 | -4.6% | 6.7% |
| 营收同比 | 126.1% | 13.6% |
| 净利润同比 | 78.4% | 143.9% |
| 每股收益（稀释后） | $-0.12 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRNCRGEN
| Q4 25 | $115.1M | $197.9M | ||
| Q3 25 | $60.6M | $188.8M | ||
| Q2 25 | $62.2M | $182.4M | ||
| Q1 25 | $78.0M | $169.2M | ||
| Q4 24 | $50.9M | $174.1M | ||
| Q3 24 | $54.8M | $154.9M | ||
| Q2 24 | $70.5M | $154.1M | ||
| Q1 24 | $67.8M | $151.3M |
净利润CRNCRGEN
| Q4 25 | $-5.2M | $13.3M | ||
| Q3 25 | $-13.4M | $14.9M | ||
| Q2 25 | $-2.7M | $14.9M | ||
| Q1 25 | $21.7M | $5.8M | ||
| Q4 24 | $-24.3M | $-30.3M | ||
| Q3 24 | $-20.4M | $-654.0K | ||
| Q2 24 | $-313.5M | $3.3M | ||
| Q1 24 | $-278.0M | $2.1M |
毛利率CRNCRGEN
| Q4 25 | 86.3% | 52.5% | ||
| Q3 25 | 72.6% | 53.2% | ||
| Q2 25 | 73.7% | 50.0% | ||
| Q1 25 | 77.1% | 53.6% | ||
| Q4 24 | 65.0% | 26.1% | ||
| Q3 24 | 63.7% | 50.0% | ||
| Q2 24 | 71.5% | 49.8% | ||
| Q1 24 | 69.2% | 49.5% |
营业利润率CRNCRGEN
| Q4 25 | 25.5% | 9.0% | ||
| Q3 25 | -2.9% | 8.9% | ||
| Q2 25 | -1.5% | 7.6% | ||
| Q1 25 | 22.2% | 3.9% | ||
| Q4 24 | -33.3% | -17.7% | ||
| Q3 24 | -35.1% | -5.1% | ||
| Q2 24 | -503.1% | 1.0% | ||
| Q1 24 | -389.8% | 1.3% |
净利率CRNCRGEN
| Q4 25 | -4.6% | 6.7% | ||
| Q3 25 | -22.0% | 7.9% | ||
| Q2 25 | -4.4% | 8.2% | ||
| Q1 25 | 27.8% | 3.4% | ||
| Q4 24 | -47.7% | -17.4% | ||
| Q3 24 | -37.3% | -0.4% | ||
| Q2 24 | -444.5% | 2.2% | ||
| Q1 24 | -409.8% | 1.4% |
每股收益（稀释后）CRNCRGEN
| Q4 25 | $-0.12 | $0.24 | ||
| Q3 25 | $-0.26 | $0.26 | ||
| Q2 25 | $-0.06 | $0.26 | ||
| Q1 25 | $0.46 | $0.10 | ||
| Q4 24 | $-0.57 | $-0.55 | ||
| Q3 24 | $-0.49 | $-0.01 | ||
| Q2 24 | $-7.50 | $0.06 | ||
| Q1 24 | $-6.66 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5M | $767.6M |
| 总债务越低越好 | $171.9M | $542.2M |
| 股东权益账面价值 | $150.4M | $2.1B |
| 总资产 | $602.0M | $2.9B |
| 负债/权益比越低杠杆越低 | 1.14× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CRNCRGEN
| Q4 25 | $2.5M | $767.6M | ||
| Q3 25 | $3.4M | $748.7M | ||
| Q2 25 | $5.5M | $708.9M | ||
| Q1 25 | $5.4M | $697.2M | ||
| Q4 24 | $3.9M | $757.4M | ||
| Q3 24 | $5.5M | $784.0M | ||
| Q2 24 | $5.4M | $809.1M | ||
| Q1 24 | $9.4M | $780.6M |
总债务CRNCRGEN
| Q4 25 | $171.9M | $542.2M | ||
| Q3 25 | $199.7M | $537.9M | ||
| Q2 25 | $198.8M | — | ||
| Q1 25 | $257.6M | — | ||
| Q4 24 | $256.2M | $525.6M | ||
| Q3 24 | $281.9M | — | ||
| Q2 24 | $280.4M | — | ||
| Q1 24 | $278.9M | — |
股东权益CRNCRGEN
| Q4 25 | $150.4M | $2.1B | ||
| Q3 25 | $150.7M | $2.1B | ||
| Q2 25 | $155.7M | $2.1B | ||
| Q1 25 | $149.3M | $2.0B | ||
| Q4 24 | $120.7M | $2.0B | ||
| Q3 24 | $141.1M | $2.0B | ||
| Q2 24 | $154.2M | $2.0B | ||
| Q1 24 | $463.4M | $2.0B |
总资产CRNCRGEN
| Q4 25 | $602.0M | $2.9B | ||
| Q3 25 | $630.6M | $2.9B | ||
| Q2 25 | $636.8M | $2.9B | ||
| Q1 25 | $665.5M | $2.9B | ||
| Q4 24 | $617.5M | $2.8B | ||
| Q3 24 | $702.4M | $2.8B | ||
| Q2 24 | $674.0M | $2.9B | ||
| Q1 24 | $987.1M | $2.8B |
负债/权益比CRNCRGEN
| Q4 25 | 1.14× | 0.26× | ||
| Q3 25 | 1.33× | 0.26× | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.73× | — | ||
| Q4 24 | 2.12× | 0.27× | ||
| Q3 24 | 2.00× | — | ||
| Q2 24 | 1.82× | — | ||
| Q1 24 | 0.60× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $37.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $35.6M | $17.6M |
| 自由现金流率自由现金流/营收 | 31.0% | 8.9% |
| 资本支出强度资本支出/营收 | 2.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $74.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CRNCRGEN
| Q4 25 | $37.9M | $25.7M | ||
| Q3 25 | $12.8M | $48.1M | ||
| Q2 25 | $23.7M | $28.6M | ||
| Q1 25 | $15.5M | $15.0M | ||
| Q4 24 | $9.3M | $39.2M | ||
| Q3 24 | $6.1M | $49.3M | ||
| Q2 24 | $12.9M | $42.2M | ||
| Q1 24 | $1.0M | $44.7M |
自由现金流CRNCRGEN
| Q4 25 | $35.6M | $17.6M | ||
| Q3 25 | $9.7M | $43.4M | ||
| Q2 25 | $16.1M | $21.5M | ||
| Q1 25 | $13.1M | $11.4M | ||
| Q4 24 | $7.9M | $33.6M | ||
| Q3 24 | $4.7M | $42.3M | ||
| Q2 24 | $12.1M | $37.4M | ||
| Q1 24 | $-801.0K | $36.4M |
自由现金流率CRNCRGEN
| Q4 25 | 31.0% | 8.9% | ||
| Q3 25 | 16.1% | 23.0% | ||
| Q2 25 | 25.8% | 11.8% | ||
| Q1 25 | 16.8% | 6.8% | ||
| Q4 24 | 15.5% | 19.3% | ||
| Q3 24 | 8.5% | 27.3% | ||
| Q2 24 | 17.1% | 24.3% | ||
| Q1 24 | -1.2% | 24.0% |
资本支出强度CRNCRGEN
| Q4 25 | 2.0% | 4.1% | ||
| Q3 25 | 5.0% | 2.5% | ||
| Q2 25 | 12.3% | 3.9% | ||
| Q1 25 | 3.0% | 2.1% | ||
| Q4 24 | 2.7% | 3.2% | ||
| Q3 24 | 2.6% | 4.5% | ||
| Q2 24 | 1.1% | 3.1% | ||
| Q1 24 | 2.7% | 5.5% |
现金转化率CRNCRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 0.71× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRNC
| License | $87.8M | 76% |
| Connected Services | $14.5M | 13% |
| Professional Services | $12.8M | 11% |
RGEN
暂无分部数据
